Key statistics
On Monday, Aethlon Medical Inc (EJU0:FRA) closed at 0.338, 69.85% above the 52 week low of 0.199 set on Aug 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.338 |
---|---|
High | 0.338 |
Low | 0.338 |
Bid | 0.376 |
Offer | 0.42 |
Previous close | 0.334 |
Average volume | 92.50 |
---|---|
Shares outstanding | 13.94m |
Free float | 13.86m |
P/E (TTM) | -- |
Market cap | 5.62m USD |
EPS (TTM) | -3.87 USD |
Data delayed at least 15 minutes, as of Nov 11 2024 07:39 GMT.
More ▼
Press releases
- Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
- Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
- Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
- Aethlon Medical to Present at Virtual Investor Conferences in September
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
- Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys
More ▼